Extraordinary General Meeting of shareholders

Mar 30, 2021

Extraordinary General Meeting (EGM) on 30 March 2021
Please find here all documents including the convocation and the agenda for the EGM scheduled on 30 March 2021.

On the registration date ("Record Time") for the EGM, Kiadis Pharma N.V. had 42,894,008 shares issued, each representing one vote.

Supporting Materials

Agenda EGM 287.9 KB

Appendix II - Post-settlement AoA - Kiadis Pharma N.V. - ENG 283.9 KB

Appendix II - Post-settlement AoA - Kiadis Pharma N.V. - NL 269.9 KB

Appendix III - Triptych AoA - Kiadis Pharma N.V_ 472.1 KB

Appendix IV - Post-delisting AoA - Kiadis Pharma B.V. - ENG 193.4 KB

Appendix IV - Post-delisting AoA - Kiadis Pharma B.V. - NL 127.2 KB

EGM 2021 Q&A Protocol 151.5 KB

Voting Results 199 KB

EGM Presentation 363.9 KB

Minutes of the EGM held on 30 March 2021 274.8 KB

Location

Amsterdam, The Netherlands

Event Details

Extraordinary General Meeting of shareholders

Mar 30, 2021

Supporting Materials

Location